fda approval ghk cu drug status adds non-injectable GHK-Cu back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 of the 503A bulks process after the nomination was withdrawn from further review. Injectable GHK-Cu remains GLOW Blend: GHK-Cu, BPC-157 &
Description
An obvious improvement in immune status parameters was recorded after the supplementation of BP in diabetic rats as an antioxidant-rich food supplement (159)
Cao C, Zou J, Liu X, Shapiro A, Moral M, Luo Z, et al
Is BPC-157 safe and are there side effects?
No formal clinical studies have evaluated this combination, and all stacking protocols derive from anecdotal research reports rather than controlled trials
